BioCentury
ARTICLE | Politics & Policy

FDA committee to discuss ASAS20 for axial spondyloarthritis

May 31, 2013 1:46 AM UTC

FDA's Arthritis Advisory Committee will meet on July 22 to discuss the use of Assessment of SpondyloArthritis International Society criteria (ASAS20) for axial spondyloarthritis, as well as the implic...